A Collaborative Model to Implement Flexible, Accessible and Efficient Oncogenetic Services for Hereditary Breast and Ovarian Cancer: The C-MOnGene Study
Author:
Lapointe Julie, Dorval Michel, Chiquette Jocelyne, Joly Yann, Guertin Jason RobertORCID, Laberge MaudeORCID, Gekas Jean, Hébert JohanneORCID, Pomey Marie-Pascale, Cruz-Marino Tania, Touhami Omar, Blanchet Saint-Pierre Arnaud, Gagnon Sylvain, Bouchard Karine, Rhéaume Josée, Boisvert Karine, Brousseau Claire, Castonguay Lysanne, Fortier Sylvain, Gosselin Isabelle, Lachapelle Philippe, Lavoie Sabrina, Poirier Brigitte, Renaud Marie-Claude, Ruizmangas Maria-Gabriela, Sebastianelli Alexandra, Roy Stéphane, Côté Madeleine, Racine Marie-Michelle, Roy Marie-Claude, Côté Nathalie, Brisson Carmen, Charette Nelson, Faucher Valérie, Leblanc Josianne, Dubeau Marie-Ève, Plante Marie, Desbiens Christine, Beaumont Martin, Simard Jacques, Nabi Hermann
Abstract
Medical genetic services are facing an unprecedented demand for counseling and testing for hereditary breast and ovarian cancer (HBOC) in a context of limited resources. To help resolve this issue, a collaborative oncogenetic model was recently developed and implemented at the CHU de Québec-Université Laval; Quebec; Canada. Here, we present the protocol of the C-MOnGene (Collaborative Model in OncoGenetics) study, funded to examine the context in which the model was implemented and document the lessons that can be learned to optimize the delivery of oncogenetic services. Within three years of implementation, the model allowed researchers to double the annual number of patients seen in genetic counseling. The average number of days between genetic counseling and disclosure of test results significantly decreased. Group counseling sessions improved participants’ understanding of breast cancer risk and increased knowledge of breast cancer and genetics and a large majority of them reported to be overwhelmingly satisfied with the process. These quality and performance indicators suggest this oncogenetic model offers a flexible, patient-centered and efficient genetic counseling and testing for HBOC. By identifying the critical facilitating factors and barriers, our study will provide an evidence base for organizations interested in transitioning to an oncogenetic model integrated into oncology care; including teams that are not specialized but are trained in genetics.
Subject
Cancer Research,Oncology
Reference59 articles.
1. Highly penetrant hereditary cancer syndromes 2. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study;Fitzmaurice;JAMA Oncol.,2017 3. Pathology of hereditary breast cancer 4. Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer 5. Hereditary Cancer Predisposition Syndromes
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|